Evidence map›Paper›PMID 37532968›Full record

ArticleMolecular biomedicine2023

Crystal structures of main protease (M

Haihai Jiang, Xiaofang Zou, Pei Zeng, Xiangyi Zeng, Xuelan Zhou, Jie Wang, Jin Zhang, Jian Li

Open access · diamondAbstract read
In one paragraph

Article in Molecular biomedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Investigation of phytochemicals isolated from selected Saudi medicinal plants as natural inhibitors of SARS CoV-2 main protease: In vitroSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  4. Leveraging SARS-CoV-2 Main Protease (MInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Haihai Jiang *School of Basic Medical Sciences, Nanchang University, Nanchang, 330031, China.ORCID http://orcid.org/0000-0002-1895-3040
Xiaofang Zou *College of Pharmaceutical Sciences, Gannan Medical University, Ganzhou, 341000, China.
Pei ZengShenzhen Crystalo Biopharmaceutical Co., Ltd., Shenzhen, 518118, China.
Xiangyi ZengShenzhen Crystalo Biopharmaceutical Co., Ltd., Shenzhen, 518118, China.
Xuelan ZhouShenzhen Crystalo Biopharmaceutical Co., Ltd., Shenzhen, 518118, China.
Jie WangShenzhen Crystalo Biopharmaceutical Co., Ltd., Shenzhen, 518118, China.
Jin ZhangSchool of Basic Medical Sciences, Nanchang University, Nanchang, 330031, China. zhangxiaokong@hotmail.com.
Jian LiCollege of Pharmaceutical Sciences, Gannan Medical University, Ganzhou, 341000, China. rmsl_2040@163.com.
Gannan Medical University · CNNanchang University · CN

Funding

CAS "Light of West China" Program xbzg-zdsys-202005Gannan Medical University QD201910Jiangxi Double Thousand Plan jxsq2019101064Jiangxi Key Research and Development Program 20203BBG73063Jiangxi Natural Science Foundation for Distinguished Young Scholars 20212ACB216001National Natural Science Foundation of China 32271260the Natural Science Foundation of Jiangxi Province 20224BAB216004
6 · The paper itself

Abstract

There is an urgent need to develop effective antiviral drugs to prevent the viral infection caused by constantly circulating SARS-CoV-2 as well as its variants. The main protease (M

Indexed as

InhibitorMain proteasePF-07304814SARS-CoV-2Variant

Identifiers

PMID37532968
PMCPMC10397169
OpenAlexW4385514342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.